Vanguard Group Inc. Has $164.62 Million Stock Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Vanguard Group Inc. increased its holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 7.8% during the fourth quarter, HoldingsChannel reports. The fund owned 21,890,422 shares of the biotechnology company’s stock after acquiring an additional 1,583,826 shares during the quarter. Vanguard Group Inc. owned 0.11% of BioCryst Pharmaceuticals worth $164,616,000 as of its most […]